Chen, Qinhong – Trademark Portfolio

Entity Type: 01

Chen, Qinhong holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ADEGRIN and APEXBOUND. The owner is based in Shenzhen,Guangdong.

A3048A,3F,No.2032,Shennan Middle Rd

Huaqiangbei St,Futian Dist

Shenzhen,Guangdong 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

APEXBOUND
APEXBOUND
Registered 2021
ADEGRIN
ADEGRIN
Registered 2021

Trademark Classifications

Chen, Qinhong's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

Frequently Asked Questions

How many trademarks does Chen, Qinhong have?

Chen, Qinhong has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Chen, Qinhong file in?

Chen, Qinhong files trademarks across 2 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 6 (Metal Goods). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.

What are Chen, Qinhong's most well-known trademarks?

Chen, Qinhong's registered trademark portfolio includes well-known marks such as ADEGRIN and APEXBOUND. These are among 2 currently registered trademarks in the portfolio.

What is Chen, Qinhong's trademark registration success rate?

Chen, Qinhong has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.